Skip to main content

Bone Biologics Corp

BBLGW
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001419554

No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $400.1K in total; no superinvestor holds it.

Other share classesBBLG

Holders of 5% or more of BBLGW

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bone Biologics Corp, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Bone Biologics Corp on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Bone Biologics Corp, newest first.

No Schedule 13D or 13G filings on Bone Biologics Corp are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Bone Biologics Corp shares.

No Form 144 notices for Bone Biologics Corp are on file.